熱門資訊> 正文
CooperCompanies因指引调整触及52周低点
2026-09-11 02:26
- CooperCompanies (COO) hit a 52-week low of $51.08 earlier on Thursday, a drop of nearly 20% from Wednesday's close, as the vision care company continued to reel from a downward change in full-year revenue and EPS guidance.
- Both fiscal 2026 guidance ranges are now below consensus figures.
- CooperCompanies also decided after a strategic review to not sell its women's health-centered CooperSurgical division. BNP Paribas analyst Navann Ty said that could have also contributed to the share decline.
- She added that CooperSurgical's flat organic growth in FY26 Q3 was "another setback relative to competitors’ operating performance."
- Cooper shares are down ~14% in Thursday afternoon trading.
More on CooperCompanies
- The Cooper Companies, Inc. (COO) Q3 2026 Earnings Call Transcript
- Cooper Companies: Cash Conversion And Strategic Optionality Create A Re-Rating Setup
- Cooper outlines Q4 2026 EPS of $1.05-$1.09 while completing strategic review and adding $1B to buyback authorization
- CooperCompanies keeping CooperSurgical; shares drop on updated guidance
- Seeking Alpha’s Quant Rating on The Cooper Companies
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
